Choi response criteria for early prediction of clinical outcome in patients with metastatic renal cell cancer treated with sunitinib

摘要

Background: Because sunitinib can induce extensive necrosis in metastatic renal cell cancer (mRCC), we examined whether criteria defined by Choi might be valuable to predict early sunitinib efficacy.